JILLIAN SONKIN: Open Payments
NPI 1639473267 · LYNBROOK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,622 in 74 payments from 20 companies in 2025. Trend: 2023 $1,820 · 2024 $2,004 · 2025 $1,622
Food & beverage: $1,622
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $308 |
| ABBVIE INC. | 10 | $211 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 8 | $191 |
| Lilly USA, LLC | 5 | $131 |
| Esperion Therapeutics, Inc. | 5 | $112 |
| Amneal Pharmaceuticals LLC | 4 | $99 |
| GlaxoSmithKline, LLC. | 6 | $98 |
| AstraZeneca Pharmaceuticals LP | 5 | $94 |
| Madrigal Pharmaceuticals | 2 | $48 |
| PFIZER INC. | 2 | $45 |
Products named: JARDIANCE, Wegovy, NEXLETOL, Ozempic, UNITHROID, TRELEGY ELLIPTA, UBRELVY, MOUNJARO.
Industry payments across NY — which companies pay providers there.
